Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorColeman, Robert
dc.contributor.authorChan, Arlene
dc.contributor.authorBarrios, Carlos
dc.contributor.authorCameron, David
dc.contributor.authorCosta, Luis
dc.contributor.authorDowsett, Mitch
dc.contributor.authorHarrison, David James
dc.contributor.authorHowell, Anthony
dc.contributor.authorLancombe, Denis
dc.contributor.authorMacKenzie, Mairead
dc.contributor.authorMartin, Miguel
dc.contributor.authorMcIntosh, Stuart
dc.contributor.authorMorgan, Adrienne
dc.contributor.authorPiccart, Martine
dc.contributor.authorSpanic, Tanja
dc.date.accessioned2022-08-27T23:43:53Z
dc.date.available2022-08-27T23:43:53Z
dc.date.issued2022-03
dc.identifier.citationColeman , R , Chan , A , Barrios , C , Cameron , D , Costa , L , Dowsett , M , Harrison , D J , Howell , A , Lancombe , D , MacKenzie , M , Martin , M , McIntosh , S , Morgan , A , Piccart , M & Spanic , T 2022 , ' Code of practice needed for samples donated by trial participants ' , The Lancet Oncology , vol. 23 , no. 3 , pp. e89-e90 . https://doi.org/10.1016/S1470-2045(22)00059-6en
dc.identifier.issn1470-2045
dc.identifier.otherPURE: 277520361
dc.identifier.otherPURE UUID: 1c2ce066-b5b5-4e2f-aaa3-a9121872c224
dc.identifier.otherORCID: /0000-0001-9041-9988/work/111547364
dc.identifier.otherScopus: 85125352929
dc.identifier.otherWOS: 000820112600001
dc.identifier.urihttps://hdl.handle.net/10023/25902
dc.language.isoeng
dc.relation.ispartofThe Lancet Oncologyen
dc.rightsCopyright © 2022 Elsevier. All rights reserved. This work has been made available online in accordance with publisher policies or with permission. Permission for further reuse of this content should be sought from the publisher or the rights holder. This is the author created accepted manuscript following peer review and may differ slightly from the final published version. The final published version of this work is available at https://doi.org/10.1016/S1470-2045(22)00059-6.en
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectRM Therapeutics. Pharmacologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccRC0254en
dc.subject.lccRMen
dc.titleCode of practice needed for samples donated by trial participantsen
dc.typeJournal itemen
dc.description.versionPostprinten
dc.contributor.institutionUniversity of St Andrews. Sir James Mackenzie Institute for Early Diagnosisen
dc.contributor.institutionUniversity of St Andrews. Cellular Medicine Divisionen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.identifier.doihttps://doi.org/10.1016/S1470-2045(22)00059-6
dc.description.statusPeer revieweden
dc.date.embargoedUntil2022-08-28


This item appears in the following Collection(s)

Show simple item record